| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.074 | 0.08 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.08 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.082 | 0.09 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |